nodes	percent_of_prediction	percent_of_DWPC	metapath
Folic Acid—Methotrexate—bone cancer	0.42	1	CrCtD
Folic Acid—GGH—Methotrexate—bone cancer	0.0803	0.306	CbGbCtD
Folic Acid—Pralatrexate—Methotrexate—bone cancer	0.0556	0.2	CrCrCtD
Folic Acid—Tetrahydrofolic acid—Methotrexate—bone cancer	0.0556	0.2	CrCrCtD
Folic Acid—Pemetrexed—Methotrexate—bone cancer	0.0556	0.2	CrCrCtD
Folic Acid—Raltitrexed—Methotrexate—bone cancer	0.0556	0.2	CrCrCtD
Folic Acid—Leucovorin—Methotrexate—bone cancer	0.0556	0.2	CrCrCtD
Folic Acid—SLC46A1—Methotrexate—bone cancer	0.0461	0.176	CbGbCtD
Folic Acid—ABCC11—Methotrexate—bone cancer	0.0386	0.147	CbGbCtD
Folic Acid—MTHFR—Methotrexate—bone cancer	0.0241	0.0919	CbGbCtD
Folic Acid—ABCC3—Cisplatin—bone cancer	0.0164	0.0625	CbGbCtD
Folic Acid—ABCC3—Doxorubicin—bone cancer	0.011	0.0419	CbGbCtD
Folic Acid—ABCC3—Methotrexate—bone cancer	0.0106	0.0406	CbGbCtD
Folic Acid—ABCC4—Methotrexate—bone cancer	0.00813	0.031	CbGbCtD
Folic Acid—ABCG2—Carboplatin—bone cancer	0.00788	0.0301	CbGbCtD
Folic Acid—ABCG2—Cisplatin—bone cancer	0.00673	0.0257	CbGbCtD
Folic Acid—FOLR3—Folate Metabolism—FOLR1—bone cancer	0.00461	0.126	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—FOLR1—bone cancer	0.00461	0.126	CbGpPWpGaD
Folic Acid—ABCG2—Doxorubicin—bone cancer	0.00451	0.0172	CbGbCtD
Folic Acid—ABCG2—Methotrexate—bone cancer	0.00437	0.0167	CbGbCtD
Folic Acid—SLC25A32—Metabolism of folate and pterines—DHFR—bone cancer	0.00358	0.0975	CbGpPWpGaD
Folic Acid—SLC22A6—Methotrexate—bone cancer	0.00354	0.0135	CbGbCtD
Folic Acid—GGH—Fluoropyrimidine Activity—DHFR—bone cancer	0.00167	0.0455	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism of folate and pterines—DHFR—bone cancer	0.00164	0.0448	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—DHFR—bone cancer	0.00127	0.0345	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—DHFR—bone cancer	0.00127	0.0345	CbGpPWpGaD
Folic Acid—SLC46A1—Folate Metabolism—FOLR1—bone cancer	0.00122	0.0331	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism of folate and pterines—DHFR—bone cancer	0.000992	0.027	CbGpPWpGaD
Folic Acid—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.00089	0.0242	CbGpPWpGaD
Folic Acid—Methotrexate—FOLR1—bone cancer	0.000795	0.325	CrCbGaD
Folic Acid—Pralatrexate—DHFR—bone cancer	0.000738	0.301	CrCbGaD
Folic Acid—MTHFR—Folate Metabolism—FOLR1—bone cancer	0.000734	0.02	CbGpPWpGaD
Folic Acid—ABCG2—HIF-2-alpha transcription factor network—CITED2—bone cancer	0.00065	0.0177	CbGpPWpGaD
Folic Acid—ABCC3—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000593	0.0161	CbGpPWpGaD
Folic Acid—Pemetrexed—DHFR—bone cancer	0.00059	0.241	CrCbGaD
Folic Acid—SLC25A32—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000583	0.0159	CbGpPWpGaD
Folic Acid—ABCC3—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000555	0.0151	CbGpPWpGaD
Folic Acid—ABCC4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000522	0.0142	CbGpPWpGaD
Folic Acid—MTHFR—One Carbon Metabolism—DHFR—bone cancer	0.0004	0.0109	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000382	0.0104	CbGpPWpGaD
Folic Acid—GGH—Fluoropyrimidine Activity—TP53—bone cancer	0.000373	0.0102	CbGpPWpGaD
Folic Acid—MTHFR—Trans-sulfuration and one carbon metabolism—DHFR—bone cancer	0.00036	0.00979	CbGpPWpGaD
Folic Acid—MTHFR—Fluoropyrimidine Activity—DHFR—bone cancer	0.000351	0.00955	CbGpPWpGaD
Folic Acid—SLC46A1—Folate Metabolism—DHFR—bone cancer	0.000334	0.00909	CbGpPWpGaD
Folic Acid—Methotrexate—DHFR—bone cancer	0.000325	0.133	CrCbGaD
Folic Acid—ABCC3—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000324	0.00883	CbGpPWpGaD
Folic Acid—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000319	0.00868	CbGpPWpGaD
Folic Acid—ABCC4—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000305	0.0083	CbGpPWpGaD
Folic Acid—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000292	0.00795	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—TP53—bone cancer	0.000283	0.0077	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—TP53—bone cancer	0.000283	0.0077	CbGpPWpGaD
Folic Acid—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000268	0.00729	CbGpPWpGaD
Folic Acid—ABCG2—Irinotecan Pathway—CYP3A4—bone cancer	0.000261	0.00711	CbGpPWpGaD
Folic Acid—ABCC3—Fluoropyrimidine Activity—DHFR—bone cancer	0.000225	0.00613	CbGpPWpGaD
Folic Acid—SLC25A32—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	0.000219	0.00596	CbGpPWpGaD
Folic Acid—ABCC4—Ectoderm Differentiation—BCOR—bone cancer	0.000219	0.00596	CbGpPWpGaD
Folic Acid—ABCC4—Fluoropyrimidine Activity—DHFR—bone cancer	0.000212	0.00576	CbGpPWpGaD
Folic Acid—MTHFR—Folate Metabolism—DHFR—bone cancer	0.000202	0.00549	CbGpPWpGaD
Folic Acid—ABCC3—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000196	0.00532	CbGpPWpGaD
Folic Acid—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000186	0.00507	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—NDUFA12—bone cancer	0.000172	0.00467	CbGpPWpGaD
Folic Acid—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000169	0.00459	CbGpPWpGaD
Folic Acid—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000162	0.0044	CbGpPWpGaD
Folic Acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000158	0.0043	CbGpPWpGaD
Folic Acid—ABCG2—Fluoropyrimidine Activity—DHFR—bone cancer	0.000155	0.00423	CbGpPWpGaD
Folic Acid—ABCC11—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000152	0.00414	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—NT5C3A—bone cancer	0.000142	0.00387	CbGpPWpGaD
Folic Acid—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.000141	0.00384	CbGpPWpGaD
Folic Acid—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000136	0.00369	CbGpPWpGaD
Folic Acid—ABCC11—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000131	0.00358	CbGpPWpGaD
Folic Acid—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000126	0.00342	CbGpPWpGaD
Folic Acid—ABCC4—Platelet degranulation—SPARC—bone cancer	0.000107	0.0029	CbGpPWpGaD
Folic Acid—ABCC4—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000101	0.00276	CbGpPWpGaD
Folic Acid—SLC46A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000101	0.00274	CbGpPWpGaD
Folic Acid—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	0.000101	0.00274	CbGpPWpGaD
Folic Acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	9.22e-05	0.00251	CbGpPWpGaD
Folic Acid—SLC46A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.7e-05	0.00237	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—NDUFA12—bone cancer	7.88e-05	0.00215	CbGpPWpGaD
Folic Acid—MTHFR—Fluoropyrimidine Activity—TP53—bone cancer	7.84e-05	0.00213	CbGpPWpGaD
Folic Acid—SLC46A1—Folate Metabolism—TP53—bone cancer	7.46e-05	0.00203	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—ENO2—bone cancer	7.44e-05	0.00203	CbGpPWpGaD
Folic Acid—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	7.24e-05	0.00197	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—DHFR—bone cancer	6.9e-05	0.00188	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—NT5C3A—bone cancer	6.53e-05	0.00178	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—ENO2—bone cancer	6.23e-05	0.0017	CbGpPWpGaD
Folic Acid—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	6.07e-05	0.00165	CbGpPWpGaD
Folic Acid—MTHFR—Selenium Micronutrient Network—PTGS2—bone cancer	6.01e-05	0.00164	CbGpPWpGaD
Folic Acid—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	5.85e-05	0.00159	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—DHFR—bone cancer	5.78e-05	0.00157	CbGpPWpGaD
Folic Acid—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	5.78e-05	0.00157	CbGpPWpGaD
Folic Acid—FOLR3—bone marrow—bone cancer	5.69e-05	0.122	CbGeAlD
Folic Acid—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	5.6e-05	0.00152	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—GNA11—bone cancer	5.4e-05	0.00147	CbGpPWpGaD
Folic Acid—ABCC3—Fluoropyrimidine Activity—TP53—bone cancer	5.03e-05	0.00137	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—TGFBR2—bone cancer	5e-05	0.00136	CbGpPWpGaD
Folic Acid—ABCC3—NRF2 pathway—TGFBR2—bone cancer	4.97e-05	0.00135	CbGpPWpGaD
Folic Acid—ABCC3—NRF2 pathway—GSTP1—bone cancer	4.97e-05	0.00135	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—CYP3A4—bone cancer	4.9e-05	0.00133	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—NDUFA12—bone cancer	4.76e-05	0.00129	CbGpPWpGaD
Folic Acid—FOLR2—connective tissue—bone cancer	4.76e-05	0.102	CbGeAlD
Folic Acid—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	4.75e-05	0.00129	CbGpPWpGaD
Folic Acid—ABCC4—Fluoropyrimidine Activity—TP53—bone cancer	4.73e-05	0.00129	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—SPARC—bone cancer	4.73e-05	0.00129	CbGpPWpGaD
Folic Acid—ABCC4—NRF2 pathway—TGFBR2—bone cancer	4.67e-05	0.00127	CbGpPWpGaD
Folic Acid—ABCC4—NRF2 pathway—GSTP1—bone cancer	4.67e-05	0.00127	CbGpPWpGaD
Folic Acid—MTHFR—Folate Metabolism—TP53—bone cancer	4.5e-05	0.00123	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—GNA11—bone cancer	4.32e-05	0.00118	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—GSTP1—bone cancer	4.19e-05	0.00114	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—NT5C3A—bone cancer	3.94e-05	0.00107	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—IL3—bone cancer	3.92e-05	0.00107	CbGpPWpGaD
Folic Acid—ABCC3—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.9e-05	0.00106	CbGpPWpGaD
Folic Acid—ABCC4—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.67e-05	0.000999	CbGpPWpGaD
Folic Acid—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	3.47e-05	0.000944	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—ENO2—bone cancer	3.42e-05	0.00093	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—KIT—bone cancer	3.41e-05	0.000929	CbGpPWpGaD
Folic Acid—ABCC3—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.37e-05	0.000918	CbGpPWpGaD
Folic Acid—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	3.33e-05	0.000906	CbGpPWpGaD
Folic Acid—SLC25A32—tendon—bone cancer	3.29e-05	0.0708	CbGeAlD
Folic Acid—FOLR2—tendon—bone cancer	3.27e-05	0.0702	CbGeAlD
Folic Acid—SLC25A32—Disease—BRAF—bone cancer	3.21e-05	0.000873	CbGpPWpGaD
Folic Acid—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.2e-05	0.00087	CbGpPWpGaD
Folic Acid—SLC25A32—bone marrow—bone cancer	3.19e-05	0.0686	CbGeAlD
Folic Acid—SLC25A32—spinal cord—bone cancer	3.18e-05	0.0683	CbGeAlD
Folic Acid—SLC46A1—Disease—DHFR—bone cancer	3.17e-05	0.000863	CbGpPWpGaD
Folic Acid—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.17e-05	0.000863	CbGpPWpGaD
Folic Acid—FOLR2—bone marrow—bone cancer	3.17e-05	0.068	CbGeAlD
Folic Acid—FOLR2—spinal cord—bone cancer	3.15e-05	0.0677	CbGeAlD
Folic Acid—ABCC3—Metabolism—NDUFA12—bone cancer	3.05e-05	0.000831	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	3.02e-05	0.000822	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—ENO2—bone cancer	2.86e-05	0.000779	CbGpPWpGaD
Folic Acid—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.76e-05	0.000751	CbGpPWpGaD
Folic Acid—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.69e-05	0.000733	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—MDM2—bone cancer	2.69e-05	0.000732	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—DHFR—bone cancer	2.65e-05	0.000723	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—PTGS2—bone cancer	2.59e-05	0.000705	CbGpPWpGaD
Folic Acid—SLC46A1—tendon—bone cancer	2.56e-05	0.055	CbGeAlD
Folic Acid—ABCC3—Metabolism—NT5C3A—bone cancer	2.53e-05	0.000689	CbGpPWpGaD
Folic Acid—CYP2E1—Biological oxidations—CYP3A4—bone cancer	2.52e-05	0.000686	CbGpPWpGaD
Folic Acid—GGH—tendon—bone cancer	2.52e-05	0.0541	CbGeAlD
Folic Acid—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	2.49e-05	0.000677	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—GNA11—bone cancer	2.48e-05	0.000675	CbGpPWpGaD
Folic Acid—SLC46A1—spinal cord—bone cancer	2.47e-05	0.053	CbGeAlD
Folic Acid—GGH—bone marrow—bone cancer	2.44e-05	0.0524	CbGeAlD
Folic Acid—ABCC4—Hemostasis—SPARC—bone cancer	2.44e-05	0.000663	CbGpPWpGaD
Folic Acid—GGH—spinal cord—bone cancer	2.43e-05	0.0521	CbGeAlD
Folic Acid—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.32e-05	0.000633	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—TGFBR2—bone cancer	2.3e-05	0.000625	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—CYP3A4—bone cancer	2.25e-05	0.000612	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—GNA11—bone cancer	2.23e-05	0.000606	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—PTGS2—bone cancer	2.17e-05	0.000591	CbGpPWpGaD
Folic Acid—CYP2E1—Biological oxidations—GSTP1—bone cancer	2.16e-05	0.000587	CbGpPWpGaD
Folic Acid—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	2.13e-05	0.000579	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NDUFA12—bone cancer	2.1e-05	0.000573	CbGpPWpGaD
Folic Acid—MTHFR—Disease—ENO2—bone cancer	2.06e-05	0.000561	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—IL3—bone cancer	2.02e-05	0.00055	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—GSTP1—bone cancer	1.92e-05	0.000524	CbGpPWpGaD
Folic Acid—MTHFR—Disease—DHFR—bone cancer	1.91e-05	0.000521	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—EGFR—bone cancer	1.84e-05	0.0005	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NT5C3A—bone cancer	1.74e-05	0.000475	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—ENO2—bone cancer	1.73e-05	0.00047	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—DHFR—bone cancer	1.6e-05	0.000436	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—KIT—bone cancer	1.57e-05	0.000427	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NDUFA12—bone cancer	1.51e-05	0.000411	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—GNA11—bone cancer	1.5e-05	0.000407	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—BRAF—bone cancer	1.47e-05	0.000401	CbGpPWpGaD
Folic Acid—MTHFR—Disease—TGFBR2—bone cancer	1.39e-05	0.000377	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—CYP3A4—bone cancer	1.36e-05	0.000369	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—PLAU—bone cancer	1.32e-05	0.000361	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NT5C3A—bone cancer	1.25e-05	0.000341	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—MDM2—bone cancer	1.23e-05	0.000336	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—PTGS2—bone cancer	1.19e-05	0.000324	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—GSTP1—bone cancer	1.16e-05	0.000316	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—ENO2—bone cancer	1.11e-05	0.000302	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—DHFR—bone cancer	1.03e-05	0.00028	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—PTGS2—bone cancer	9.97e-06	0.000271	CbGpPWpGaD
Folic Acid—ABCC4—tendon—bone cancer	9.83e-06	0.0211	CbGeAlD
Folic Acid—ABCC3—Metabolism—GNA11—bone cancer	9.61e-06	0.000262	CbGpPWpGaD
Folic Acid—ABCC4—bone marrow—bone cancer	9.52e-06	0.0204	CbGeAlD
Folic Acid—MTHFR—Disease—KIT—bone cancer	9.46e-06	0.000257	CbGpPWpGaD
Folic Acid—MTHFR—Disease—BRAF—bone cancer	8.89e-06	0.000242	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CYP3A4—bone cancer	8.71e-06	0.000237	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.67e-06	0.000236	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—EGFR—bone cancer	8.43e-06	0.00023	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—ENO2—bone cancer	7.64e-06	0.000208	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—GSTP1—bone cancer	7.45e-06	0.000203	CbGpPWpGaD
Folic Acid—MTHFR—Disease—MDM2—bone cancer	7.45e-06	0.000203	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PTGS2—bone cancer	7.18e-06	0.000195	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—DHFR—bone cancer	7.09e-06	0.000193	CbGpPWpGaD
Folic Acid—ABCG2—bone marrow—bone cancer	6.72e-06	0.0144	CbGeAlD
Folic Acid—ABCG2—spinal cord—bone cancer	6.69e-06	0.0144	CbGeAlD
Folic Acid—ABCG2—Metabolism—GNA11—bone cancer	6.62e-06	0.00018	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PTGS2—bone cancer	6.01e-06	0.000164	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP3A4—bone cancer	6.01e-06	0.000163	CbGpPWpGaD
Folic Acid—CYP2E1—tendon—bone cancer	6e-06	0.0129	CbGeAlD
Folic Acid—CYP2E1—spinal cord—bone cancer	5.79e-06	0.0124	CbGeAlD
Folic Acid—CYP2E1—Metabolism—ENO2—bone cancer	5.49e-06	0.000149	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—TP53—bone cancer	5.33e-06	0.000145	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTP1—bone cancer	5.14e-06	0.00014	CbGpPWpGaD
Folic Acid—MTHFR—Disease—EGFR—bone cancer	5.09e-06	0.000139	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—DHFR—bone cancer	5.09e-06	0.000139	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GNA11—bone cancer	4.76e-06	0.000129	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP3A4—bone cancer	4.31e-06	0.000117	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PTGS2—bone cancer	3.86e-06	0.000105	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTP1—bone cancer	3.69e-06	0.0001	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PTGS2—bone cancer	2.66e-06	7.24e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PTGS2—bone cancer	1.91e-06	5.2e-05	CbGpPWpGaD
